WST Stock Ownership Activity

WEST PHARMACEUTICAL SERVICES 13F holders

2 value investing gurus have made changes to the WEST PHARMACEUTICAL SERVICES (WST) position according to the gurus' latest SEC quarterly report(s). WST has been bought (as a new position) by 1 guru(s), the number of WST shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying WST now?

According to the latest SEC filing(s) WEST PHARMACEUTICAL SERVICES (WST) has been bought by 2 gurus: Henry Ellenbogen - Durable Capital Partners (added shares +146.8%) and Bill Gates - Bill & Melinda Gates Foundation Trust (new buy).

To see more about who is investing in WEST PHARMACEUTICAL SERVICES (WST), please go to the WST ownership page.

2025 Q1 (2 results)
Bill Gates
buy
+444,500
+0.24%
0.24%
Henry Ellenbogen
+146.80%
+935,721
+1.87%
3.15%
Current price: $218.58 2.37% AVG reported price*: $223.88
2024 Q4 (1 result)
Henry Ellenbogen
-41.30%
-448,521
-1.20%
1.70%
Current price: $218.58 33.27% Reported price*: $327.56
2024 Q3 (1 result)
Henry Ellenbogen
+4.36%
+45,395
+0.10%
2.38%
Current price: $218.58 27.18% Reported price*: $300.16
2024 Q2 (1 result)
Henry Ellenbogen
+0.92%
+9,471
+0.03%
2.81%
Current price: $218.58 33.64% Reported price*: $329.39
2024 Q1 (1 result)
Henry Ellenbogen
-9.46%
-107,677
-0.33%
3.16%
Current price: $218.58 44.76% Reported price*: $395.71
2023 Q4 (1 result)
Henry Ellenbogen
-5.27%
-63,339
-0.18%
3.17%
Current price: $218.58 37.92% Reported price*: $352.12
2023 Q3 (1 result)
Henry Ellenbogen
-5.98%
-76,506
-0.26%
4.12%
Current price: $218.58 41.74% Reported price*: $375.21
2023 Q2 (1 result)
Henry Ellenbogen
+2.96%
+36,757
+0.12%
4.29%
Current price: $218.58 42.85% Reported price*: $382.47
2023 Q1 (1 result)
Henry Ellenbogen
+11.51%
+128,134
+0.42%
4.04%
Current price: $218.58 36.91% Reported price*: $346.47
2022 Q4 (1 result)
Henry Ellenbogen
-5.58%
-65,763
-0.16%
2.72%
Current price: $218.58 7.13% Reported price*: $235.35
2022 Q3 (1 result)
Henry Ellenbogen
+18.65%
+185,411
+0.50%
3.19%
Current price: $218.58 11.18% Reported price*: $246.08
2022 Q2 (1 result)
Henry Ellenbogen
+32.83%
+245,705
+0.85%
3.45%
Current price: $218.58 27.71% Reported price*: $302.37
2022 Q1 (1 result)
Henry Ellenbogen
-12.90%
-110,879
-0.40%
2.70%
Current price: $218.58 46.78% Reported price*: $410.71
2021 Q3 (1 result)
Henry Ellenbogen
-9.68%
-92,053
-0.30%
2.76%
Current price: $218.58 48.51% Reported price*: $424.54
2021 Q2 (1 result)
Henry Ellenbogen
-1.79%
-17,362
-0.05%
2.52%
Current price: $218.58 39.13% Reported price*: $359.10
2020 Q4 (1 result)
Henry Ellenbogen
-12.43%
-137,493
-0.35%
2.44%
Current price: $218.58 22.85% Reported price*: $283.31
2020 Q3 (1 result)
Henry Ellenbogen
-10.88%
-135,073
-0.41%
3.35%
Current price: $218.58 20.49% Reported price*: $274.90
2020 Q2 (1 result)
Henry Ellenbogen
+31.65%
+298,370
+0.84%
3.51%
Current price: $218.58 3.78% Reported price*: $227.17
2020 Q1 (1 result)
Henry Ellenbogen
buy
+942,821
+2.92%
2.92%
Current price: $218.58 43.57% Reported price*: $152.25
20 of 20

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.